TC
COLL icon

Truvestments Capital’s Collegium Pharmaceutical COLL Stock Holding History

Truvestments Capital’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$5.14K Sell
142
-216
-60% -$7.38K ﹤0.01% 898
2026
Q1 		$11.8K Sell
358
-76
-18% -$3.22K ﹤0.01% 729
2025
Q4 		$20.1K Hold
434
– – ﹤0.01% 590
2025
Q3 		$15.2K Sell
434
-195
-31% -$6.78K ﹤0.01% 649
2025
Q2 		$18.6K Hold
629
– – ﹤0.01% 548
2025
Q1 		$18.8K Sell
629
-42
-6% -$1.28K ﹤0.01% 563
2024
Q4 		$19.2K Buy
671
+208
+45% +$6.88K ﹤0.01% 502
2024
Q3 		$17.9K Buy
+463
New +$16.5K ﹤0.01% 507
2024
Q2 		– Sell
-358
Closed -$13.9K – 315
2024
Q1 		$13.9K Hold
358
– – 0.01% 469
2023
Q4 		$11K Hold
358
– – 0.01% 511
2023
Q3 		$8K Hold
358
– – ﹤0.01% 467
2023
Q2 		$7.69K Hold
358
– – ﹤0.01% 476
2023
Q1 		$8.59K Buy
358
+85
+31% +$2.25K ﹤0.01% 449
2022
Q4 		$6.33K Sell
273
-70
-20% -$1.41K ﹤0.01% 516
2022
Q3 		$5K Hold
343
– – ﹤0.01% 466
2022
Q2 		$6K Buy
+343
New +$5.77K ﹤0.01% 460
2022
Q1 		– Sell
-212
Closed -$4K – 256
2021
Q4 		$4K Hold
212
– – ﹤0.01% 500
2021
Q3 		$4K Hold
212
– – ﹤0.01% 466
2021
Q2 		$5K Hold
212
– – ﹤0.01% 455
2021
Q1 		$5K Sell
212
-26
-11% -$618 ﹤0.01% 519
2020
Q4 		$4K Buy
+238
New +$4.65K ﹤0.01% 506
2020
Q3 		– Sell
-238
Closed -$4K – 363
2020
Q2 		$4K Buy
+238
New +$4.66K ﹤0.01% 470
2019
Q4 		– Sell
-411
Closed -$5K – 234
2019
Q3 		$5K Sell
411
-37
-8% -$422 ﹤0.01% 568
2019
Q2 		$6K Hold
448
– – ﹤0.01% 590
2019
Q1 		$7K Buy
+448
New +$7.17K 0.01% 557
2018
Q3 		$7K Buy
+466
New +$8.26K ﹤0.01% 696

Other funds holding COLL

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fuller & Thaler Asset Management
Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Truvestments Capital's COLL Position: Q2 2026 in Review

Truvestments Capital reduced its Collegium Pharmaceutical (COLL) stake by 60% in Q2 2026, selling an estimated $7.38K and leaving 142 shares worth $5.14K. The position accounts for ﹤0.01% of the portfolio, ranked #898.

Truvestments Capital first reported a position in COLL in Q3 2018 and has held it in 26 quarters since. The position peaked at $20.1K in Q4 2025. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

  • Truvestments Capital held 142 shares of Collegium Pharmaceutical worth $5.14K as of Q2 2026.
  • Truvestments Capital sold 216 Collegium Pharmaceutical shares in Q2 2026, an estimated $7.38K.
  • Collegium Pharmaceutical made up ﹤0.01% of Truvestments Capital's portfolio in Q2 2026, its #898 holding.
  • Truvestments Capital first reported a position in Collegium Pharmaceutical in Q3 2018 and has held it in 26 quarters since.
  • Truvestments Capital's Collegium Pharmaceutical position peaked at $20.1K in Q4 2025.
  • 279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.